Home / Business and Economy / FTC Blocks Edwards Lifesciences Acquisition
FTC Blocks Edwards Lifesciences Acquisition
10 Jan
Summary
- US FTC successfully blocked Edwards Lifesciences' acquisition.
- Jenavalve Technology Inc. was the target company in the deal.
- The ruling was issued by a court on Friday, January 9.
A U.S. Federal Trade Commission effort has successfully halted the proposed acquisition of Jenavalve Technology Inc. by Edwards Lifesciences Corp. A court issued its ruling on Friday, January 9, to block the deal.
This judicial decision means that Edwards Lifesciences will not be able to acquire Jenavalve Technology as previously planned. The FTC's intervention underscores regulatory scrutiny over mergers and acquisitions.
The ruling by the court marks a definitive stop to the transaction. Further details regarding the FTC's specific concerns leading to this action were not immediately available.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
